ReviewFrontiers in immunology2026
Inflammation in hepatocellular carcinoma progression: a "Single Wick, dual interwoven strands" regulatory framework.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatocellular carcinoma (HCC) is one of the most prevalent and lethal malignancies worldwide, with chronic liver inflammation as the core driver of its initiation and progression. Regardless of etiology, HCC development follows the classic progressive pathway of "chronic inflammation - liver fibrosis - cirrhosis - liver cancer". In this review, we propose an innovative "Single Wick, Dual Interwoven Strands" regulatory framework to systematically delineate the role of inflammation in the entire continuum of HCC progression. We define chronic liver inflammation as the "Wick" - the core driver that initiates and sustains the pro-tumor cascade, while inflammatory cells and inflammatory cytokines act as the two interwoven functional "Strands" that execute the pro-carcinogenic effects of inflammation via a tightly regulated interactive network. Their synergistic crosstalk drives five core terminal biological outcomes of HCC progression: invasion and metastasis, angiogenesis, immune escape, metabolic reprogramming, and therapeutic resistance. Based on this framework, we dissect the core mechanisms of inflammation-driven HCC, summarize the latest advances in inflammation-targeted diagnostic, therapeutic and preventive strategies, and highlight the clinical translational prospects of this framework. This work provides systematic theoretical guidance for early prevention, precise treatment and prognosis improvement of HCC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.